Intriguingly, 63% of the genes activated in fibroblasts during microtumor growth with HCT116 KRAS-driven tumor cells were also activated when cultured with HT-29 BRAF-driven tumor cells (Figure 4B and Supplementary Table 3). The gene discussed is BRAF; the disease is neoplasm.